SCM
XBI icon

Silverarc Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Silverarc Capital Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-300,000
Closed -$21.9M – 89
2023
Q3 		$21.9M Buy
+300,000
New +$24M 6.64% 1
2022
Q3 		– Sell
-208,300
Closed -$15.5M – 92
2022
Q2 		$15.5M Sell
208,300
-91,700
-31% -$6.88M 4.76% 3
2022
Q1 		$27M Buy
300,000
+100,000
+50% +$9.23M 11.16% 2
2021
Q4 		$22.4M Buy
+200,000
New +$24.1M 9.07% 1
2021
Q3 		– Sell
-94,400
Closed -$12.8M – 108
2021
Q2 		$12.8M Buy
+94,400
New +$12.4M 5.7% 1

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return